case report aspiration during anesthesia glp-1 receptor agonist 2023 Glucagon-Like Peptide-1 (GLP-1) Agonists: Risk of American Society for Gastrointestinal Endoscopy

Incretin-Based Glucose-Lowering Medications and the Risk of Acute Pancreatitis and Malignancies: A Meta-Analysis Based on Cardiovascular Outcomes Trials

Allodynia (skin tenderness) associated with semaglutide: a case series

10.1111/j.1463-1326.2011.01454.x

Glucagon-Like Peptide-1: A Multi-Faceted Anti-Inflammatory Agent

Several GLP-1 medications were first approved for type 2 diabetes, but some patients were later prescribed off-label versions of these drugs for weight loss before separate obesity-specific formulations became available

GLP-1 drugs, also called GLP-1 agonists, are shortened names for glucagon-like peptide-1 receptor agonists